How Does Mind’s AI-Driven Mental Healthcare Transform Care?
Introduction
On June 17, 2025, Sword Health, a trailblazing healthtech startup, announced a €34.6 million ($40 million) funding round at a €3.4 billion ($4 billion) valuation, led by General Catalyst. The
Transparency in Industry Partnerships: Building Trust
This update emphasizes transparency in industry partnerships as essential for building trust and prioritizing patient care. It highlights EFPIA’s mandatory disclosure requirements for financial interactions with healthcare professionals (HCPs) and patient organizations (POs) through its Disclosur...
DALY Modeling Methods for Enhanced Health Economics and Policy Analysis
How can DALY modeling methods enhance health policy and economic evaluation?
DALY modeling methods (Disability-Adjusted Life-Year estimation techniques) are central to health economics. They empower analysts and policymakers to quantify disease burden, compare interventions, a...
Pharmaceutical Pricing Issues: Beyond Overpricing and Profit Motives
The BMJ article "The drug industry’s crimes and misdemeanours extend far beyond overpricing in the US" sharply critiques pharmaceutical pricing issues, arguing that profit-driven motives dominate. The discussion highlights recent decisions by the UK's NICE to deny coverage for costly
Cell Therapy for Type 1 Diabetes: Vertex Trial Results and Market Potential
Cell therapy for type 1 diabetes (T1D) offers hope for restoring insulin production in a condition where autoimmune destruction of pancreatic beta cells requires lifelo...
Biosimilar Clinical Approach
What is the biosimilar clinical approach, and how is it changing biosimilar approvals in the EU?
The biosimilar clinical approach—as outlined in the latest EMA guidance on...
